Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
5706
mi
from 91732
Marseille,
Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
5706
mi
from 91732
Marseille,
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2277
mi
from 91732
Bethesda, MD
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2277
mi
from 91732
Bethesda, MD
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2202
mi
from 91732
Durham, NC
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2184
mi
from 91732
Charleston, SC
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Research Site
8190
mi
from 91732
Adelaide,
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Research Site
8190
mi
from 91732
Adelaide,
Click here to add this to my saved trials
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Multicenter Open-label Study to Evaluate Efficacy of Gadobutrol-enhanced Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Significant Coronary Artery Disease (CAD) in Subjects With Known or Suspected CAD by a Blinded Image Analysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER) Specific Aim 3b
PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER), Specific Aim 3b
Status: Enrolling
Updated:  12/31/1969
San Jose Medical Center - Kaiser Permanente
304
mi
from 91732
San Jose, CA
PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER) Specific Aim 3b
PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER), Specific Aim 3b
Status: Enrolling
Updated: 12/31/1969
San Jose Medical Center - Kaiser Permanente
304
mi
from 91732
San Jose, CA
Click here to add this to my saved trials
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study
Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use.
Status: Enrolling
Updated:  12/31/1969
Abbott Vascular
318
mi
from 91732
Santa Clara, CA
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study
Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use.
Status: Enrolling
Updated: 12/31/1969
Abbott Vascular
318
mi
from 91732
Santa Clara, CA
Click here to add this to my saved trials
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System
327
mi
from 91732
Palo Alto, CA
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System
327
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical School
328
mi
from 91732
Stanford, CA
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical School
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
2281
mi
from 91732
Washington,
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
The Cardiac and Vascular Institute
2100
mi
from 91732
Gainesville, FL
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
The Cardiac and Vascular Institute
2100
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
University of Florida
2104
mi
from 91732
Gainesville, FL
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Florida
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
First Coast Cardiovascular Institute
2135
mi
from 91732
Jacksonville, FL
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
First Coast Cardiovascular Institute
2135
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Medical Center
1713
mi
from 91732
Elk Grove Village, IL
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Medical Center
1713
mi
from 91732
Elk Grove Village, IL
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Bayview Medical Center
2304
mi
from 91732
Baltimore, MD
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Bayview Medical Center
2304
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
2578
mi
from 91732
Boston, MA
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian-Weill Cornell Medical Center
2435
mi
from 91732
New York, NY
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian-Weill Cornell Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
OhioHealth Research Institute
1960
mi
from 91732
Columbus, OH
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
OhioHealth Research Institute
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
University of Toledo Medical Center
1932
mi
from 91732
Toledo, OH
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Toledo Medical Center
1932
mi
from 91732
Toledo, OH
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Holy Spirit Hospital
2281
mi
from 91732
Camp Hill, PA
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Holy Spirit Hospital
2281
mi
from 91732
Camp Hill, PA
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
South Carolina Heart Center
2106
mi
from 91732
Columbia, SC
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
South Carolina Heart Center
2106
mi
from 91732
Columbia, SC
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Greenville Hospital System
2023
mi
from 91732
Greenville, SC
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Greenville Hospital System
2023
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Holston Valley Hospital
1994
mi
from 91732
Kingsport, TN
Zilver® PTX® V Clinical Study
Zilver® PTX® Drug-Eluting Peripheral Stent Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Holston Valley Hospital
1994
mi
from 91732
Kingsport, TN
Click here to add this to my saved trials
Resolute Integrity US Extended Length Sub-Study(RI US XL)
Resolute Integrity US A Postapproval Study of the Medtronic Resolute™ Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital Health Center
2319
mi
from 91732
Syracuse, NY
Resolute Integrity US Extended Length Sub-Study(RI US XL)
Resolute Integrity US A Postapproval Study of the Medtronic Resolute™ Integrity Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2 mm
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital Health Center
2319
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
24
mi
from 91732
Santa Ana, CA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
24
mi
from 91732
Torrance, CA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
24
mi
from 91732
Torrance, CA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
70
mi
from 91732
Ventura, CA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
70
mi
from 91732
Ventura, CA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2117
mi
from 91732
Clearwater, FL
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2117
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1977
mi
from 91732
Tallahassee, FL
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1977
mi
from 91732
Tallahassee, FL
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1927
mi
from 91732
Tucker, GA
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1927
mi
from 91732
Tucker, GA
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1714
mi
from 91732
Arlington Heights, IL
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1714
mi
from 91732
Arlington Heights, IL
Click here to add this to my saved trials
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1728
mi
from 91732
Englewood, IL
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1728
mi
from 91732
Englewood, IL
Click here to add this to my saved trials